These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 38926784)

  • 1. Association of MAFLD and MASLD with all-cause and cause-specific dementia: a prospective cohort study.
    Bao X; Kang L; Yin S; Engström G; Wang L; Xu W; Xu B; Zhang X; Zhang X
    Alzheimers Res Ther; 2024 Jun; 16(1):136. PubMed ID: 38926784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steatotic liver disease-associated all-cause/cause-specific mortality in the United States.
    Kim D; Wijarnpreecha K; Cholankeril G; Ahmed A
    Aliment Pharmacol Ther; 2024 Jul; 60(1):33-42. PubMed ID: 38649335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians.
    Wu T; Ye J; Mo S; Ye M; Li X; Li Q; Wang W; Zheng Q; Luo K; Zhang Y; Tu S; Che D; Gong R; Chen X; Miu R; Shao C; Sun Y; Zhong B
    J Gastroenterol Hepatol; 2024 Aug; 39(8):1636-1647. PubMed ID: 38695344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity and Remission of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence.
    Gao J; Li Y; Zhang Y; Zhan X; Tian X; Li J; Wang R; He Y; Wang A; Wu S
    J Am Heart Assoc; 2024 Mar; 13(5):e032604. PubMed ID: 38390843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification.
    Kang MK; Song JE; Loomba R; Park SY; Tak WY; Kweon YO; Lee YR; Park JG
    Sci Rep; 2024 Oct; 14(1):22917. PubMed ID: 39358447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of physical activity with MAFLD/MASLD and LF among adults in NHANES, 2017-2020.
    Li M
    Wien Klin Wochenschr; 2024 May; 136(9-10):258-266. PubMed ID: 38170220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults.
    Song R; Li Z; Zhang Y; Tan J; Chen Z
    Liver Int; 2024 Apr; 44(4):1051-1060. PubMed ID: 38293788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breaking new ground: MASLD vs. MAFLD-which holds the key for risk stratification?
    Ramírez-Mejía MM; Jiménez-Gutiérrez C; Eslam M; George J; Méndez-Sánchez N
    Hepatol Int; 2024 Feb; 18(1):168-178. PubMed ID: 38127259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAFLD predicts cardiovascular disease risk better than MASLD.
    Pan Z; Shiha G; Esmat G; Méndez-Sánchez N; Eslam M
    Liver Int; 2024 Jul; 44(7):1567-1574. PubMed ID: 38641962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and mortality outcomes of patients with MASLD only compared to those with MAFLD and MASLD.
    Jiang M; Pan Z; George J; Eslam M
    Hepatol Int; 2024 Dec; 18(6):1731-1739. PubMed ID: 39196505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-Life Metabolic Dysfunction-Associated Steatotic Liver Disease and its Association With Physical Disability and Dementia.
    Clayton-Chubb D; Kemp WW; Majeed A; Woods RL; Ryan J; Murray AM; Chong TTJ; Lubel JS; Tran C; Hodge AD; Schneider HG; McNeil JJ; Roberts SK
    J Gerontol A Biol Sci Med Sci; 2024 Apr; 79(4):. PubMed ID: 38227760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease.
    Pan Z; Derbala M; AlNaamani K; Ghazinian H; Fan JG; Eslam M
    Ann Hepatol; 2024; 29(5):101512. PubMed ID: 38710473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAFLD identifies patients with significant hepatic fibrosis better than MASLD.
    Pan Z; Al-Busafi SA; Abdulla M; Fouad Y; Sebastiani G; Eslam M
    Hepatol Int; 2024 Jun; 18(3):964-972. PubMed ID: 38717690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up.
    Choe HJ; Moon JH; Kim W; Koo BK; Cho NH
    Metabolism; 2024 Apr; 153():155800. PubMed ID: 38266957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between new-onset atrial fibrillation and dementia among individuals with type 2 diabetes.
    Zhou Y; Xu M; Yin X; Gong Y
    Diabetes Obes Metab; 2024 Sep; 26(9):3715-3722. PubMed ID: 38874105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of pro-inflammatory diet with increased risk of all-cause dementia and Alzheimer's dementia: a prospective study of 166,377 UK Biobank participants.
    Shi Y; Lin F; Li Y; Wang Y; Chen X; Meng F; Ye Q; Cai G
    BMC Med; 2023 Jul; 21(1):266. PubMed ID: 37480061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygenic risk score of metabolic dysfunction-associated steatotic liver disease amplifies the health impact on severe liver disease and metabolism-related outcomes.
    Xiao L; Li Y; Hong C; Ma P; Zhu H; Cui H; Zou X; Wang J; Li R; He J; Liang S; Li Z; Zeng L; Liu L
    J Transl Med; 2024 Jul; 22(1):650. PubMed ID: 38997780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Linear Association of Dietary Polyamines with the Risk of Incident Dementia: Results from Population-Based Cohort of the UK Biobank.
    Qian M; Zhang N; Zhang R; Liu M; Wu Y; Lu Y; Li F; Zheng L
    Nutrients; 2024 Aug; 16(16):. PubMed ID: 39203912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.
    Song Z; Miao X; Xie X; Tang G; Deng J; Hu M; Liu S; Leng S
    Lipids Health Dis; 2024 May; 23(1):141. PubMed ID: 38760825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary patterns in the progression of metabolic dysfunction-associated fatty liver disease to advanced liver disease: a prospective cohort study.
    Li T; Zhao J; Cao H; Han X; Lu Y; Jiang F; Li X; Sun J; Zhou S; Sun Z; Wang W; Ding Y; Li X
    Am J Clin Nutr; 2024 Sep; 120(3):518-527. PubMed ID: 39029661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.